Combination of pulse methylprednisolone infusions with cyclosporine‐based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation

Seiichiro Shishido(Toho University), Atsushi Aikawa(Toho University), Hiroshi Asanuma(Meiji University of Integrative Medicine), Yuko Hamasaki(Toho University), Hiroyuki Satou(Boston Children's Hospital), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Kenji Ishikura(Kitasato University), Masataka Honda(Rikkyo University), Masaki Muramatsu(Queen Mary University of London)
Clinical Transplantation
February 6, 2013
10.1111/ctr.12079
Cited by 32

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135